You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Reverse Phase Microarrays

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor

Enrolling by invitation
  • Cystic Fibrosis
    • Denver, Colorado
    • +1 more
    Apr 7, 2023

    Heart Failure With Preserved Ejection Fraction Trial (CDR132L, Placebo)

    Not yet recruiting
    • Heart Failure With Preserved Ejection Fraction
    • (no location specified)
    Jul 18, 2023

    Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

    Active, not recruiting
    • Chronic Hepatitis B
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Apr 20, 2023

    Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

    Recruiting
    • Colorectal Cancer
    • Pisa, PI, Italy
      U.O. Oncologia 2 Universitaria
    Aug 3, 2022

    HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

    Active, not recruiting
    Has Results
    • HIV-1 Infection
    • Doravirine, Tenofovir, Lamivudine
    • +4 more
    • (no location specified)
    Sep 2, 2022

    Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Sham)

    Completed
    • Leber Hereditary Optic Neuropathy
    • GS010
    • Sham
    • Pasadena, California
    • +6 more
    Jul 25, 2022

    Foot Drop, Stroke, Hemiparesis Trial in Baltimore (Unpowered Physical Therapy Robot (Phase I/Phase II), PTR Physical Therapy

    Recruiting
    • Foot Drop
    • +2 more
    • PTR Physical Therapy while wearing Robot group (Phase II)
    • +3 more
    • Baltimore, Maryland
      University of Maryland Rehabilitation & Orthopaedic Institute
    Jan 24, 2023

    HIV-1-infection Trial in Johannesburg (Doravirine/Lamivudine/Tenofovir)

    Recruiting
    • HIV-1-infection
    • Johannesburg, Gauteng, South Africa
    • +2 more
    Jun 6, 2022

    Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)

    Recruiting
    • Chronic Hepatitis B
    • VRON-0200-AdC6
    • VRON-0200-AdC7
    • Hong Kong, Hong Kong
    • +1 more
    Oct 6, 2023

    Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))

    Recruiting
    • Breast Cancer
    • Saint Louis, Missouri
    • +2 more
    Jan 12, 2023

    Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer Trial in Birmingham (Avelumab, Sunitinib)

    Withdrawn
    • Clear-cell Renal Cell Carcinoma
    • +3 more
    • Birmingham, Alabama
      University of Alabama Hematology Oncology Clinic at Medical West
    Feb 14, 2022

    Metastatic Breast Cancer Trial in Italy (Eribulin Mesylate, Capecitabine)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Brescia, Italy
    • +24 more
    Apr 18, 2023

    Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)

    Completed
    Has Results
    • Breast Cancer
    • Cardiac Toxicity
    • trastuzumab
    • +11 more
    • Rochester, Minnesota
      Mayo Clinic Cancer Research Consortium
    Jul 12, 2022

    HIV-1 Infection Trial (Doravirine/lamivudine/tenofovir disoproxil fumarate)

    Completed
    Has Results
    • HIV-1 Infection
    • Doravirine/lamivudine/tenofovir disoproxil fumarate
    • (no location specified)
    Oct 7, 2021

    Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,

    Recruiting
    • Chronic HBV Infection
    • Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
    • +2 more
    • Beijing, Beijing, China
    • +7 more
    Feb 23, 2023

    HIV-1 Trial in Panama, South Africa, United States (F/TAF, 3rd ARV agent, Boosted PIs)

    Active, not recruiting
    Has Results
    • HIV-1
    • Los Angeles, California
    • +7 more
    Nov 11, 2022

    Maternal-fetal Infection Transmission Trial in France (darunavir monotherapy)

    Completed
    • Maternal-fetal Infection Transmission
    • darunavir monotherapy
    • Argenteuil, France
    • +22 more
    Aug 5, 2021

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • Cyclophosphamide (Non-IMP, Lymphodepletion)
    • +3 more
    • Ulm, Baden-Württemberg, Germany
    • +4 more
    Jul 24, 2023

    Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

    Recruiting
    • Melanoma
    • +7 more
    • Nivolumab or Pembrolizumab (dependent upon approved indication)
    • +2 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Feb 10, 2022

    HIV-1-infection Trial in Kampala, Harare (GS-9131, BIC, TAF)

    Terminated
    Has Results
    • HIV-1-infection
    • Kampala, Uganda
    • +1 more
    Dec 7, 2020

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Suspended
    • Anatomic Stage I Breast Cancer AJCC v8
    • +23 more
    • Short-Term Fasting
    • Chemotherapy
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 23, 2023

    Chronic Systolic Heart Failure Trial in China (Neucardin, Placebo)

    Recruiting
    • Chronic Systolic Heart Failure
    • Beijing, Beijing, China
    • +79 more
    Jul 9, 2023

    Post-Acute COVID-19 Syndrome Trial in United States (Baricitinib 4 MG)

    Not yet recruiting
    • Post-Acute COVID-19 Syndrome
    • Baricitinib 4 MG
    • San Francisco, California
    • +5 more
    May 11, 2023

    Deep Neuromuscular Blockade, Anesthesia, General Trial (Sugammadex)

    Not yet recruiting
    • Deep Neuromuscular Blockade
    • Anesthesia, General
    • (no location specified)
    May 2, 2023

    HIV Trial in Worldwide (GSK3640254, ABC/3TC, FTC/TAF)

    Active, not recruiting
    • HIV Infections
    • Los Angeles, California
    • +65 more
    Jul 18, 2022